Rev Panam Salud Publica. 2024 May 16;48:e51. doi: 10.26633/RPSP.2024.51. eCollection 2024.
Hypertensive disorders during pregnancy are a major cause of severe morbidity, long-term disability, and death. Appropriate pharmacological treatment is essential in the management of these disorders.
Synthesize the recommendations developed by the World Health Organization (WHO) to improve the quality of care and health outcomes of adults with high blood pressure, and address aspects of how to implement these recommendations.
A synthesis was conducted of and . The WHO recommendations follow the GRADE methodology (Grading of Recommendations, Assessment, Development, and Evaluation) for the preparation of guidelines, as described in the WHO Handbook for Guideline Development. In addition, a systematic search for studies carried out in the Region of the Americas was conducted in PubMed, Lilacs, Health Systems Evidence, Epistemonikos, and gray literature to identify barriers, facilitators, and implementation strategies.
Four recommendations were formulated for women with hypertensive disorders. Implementation barriers and facilitators were identified, and indicators were created to assess adherence and outcomes.
The formulated recommendations provide guidance on how to approach drug treatment of hypertension in pregnancy, with considerations for implementation in Latin America and the Caribbean.
妊娠期高血压疾病是严重发病、长期残疾和死亡的主要原因。适当的药物治疗对这些疾病的管理至关重要。
综合世界卫生组织(WHO)制定的建议,以提高成人高血压患者的护理质量和健康结局,并探讨如何实施这些建议。
对[具体内容未给出]进行了综合分析。WHO的建议遵循《WHO指南制定手册》中所述的用于制定指南的GRADE方法(建议分级、评估、制定和评价)。此外,在PubMed、Lilacs、卫生系统证据、Epistemonikos和灰色文献中对在美洲地区开展的研究进行了系统检索,以确定障碍、促进因素和实施策略。
针对患有高血压疾病的女性制定了四项建议。确定了实施障碍和促进因素,并创建了评估依从性和结局的指标。
制定的建议为如何进行妊娠期高血压的药物治疗提供了指导,并考虑在拉丁美洲和加勒比地区实施。